CLINSQUARE: CLINICAL RESEARCH COURSES
Tuesday, April 22, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

Gilead Sciences Statement on Positive Data Emerging From National Institute of Allergy and Infectious Diseases’ Study of Investigational Antiviral Remdesivir for COVID-19

admin - 0
April 29, 2020: "Gilead Sciences. Inc. is aware of positive data emerging from the National Institute of Allergy and Infectious Diseases’ (NIAID) study of the investigational...

Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19

admin - 0
April 29, 2020: "Gilead Sciences, Inc. announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and 10-day dosing durations of the...

Paradigm Biopharmaceuticals completes Zilosul dosing under FDA’s Expanded Access Program

admin - 0
April 29, 2020: "Paradigm Biopharmaceuticals Ltd has completed dosing of all ten patients with Zilosul® under the FDA’s Investigational New Drug Expanded Access Program...

Antibodies from llamas could help in the fight against COVID-19

admin - 0
April 29, 2020: "The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their...

Coronavirus (COVID-19) Update: Daily Roundup April 29, 2020

admin - 0
April 29, 2020: "The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19...

FDA Grants Marketing of New Device for Continuous Dialysis Therapy for Use in Pediatric Patients with Certain Kidney Conditions

admin - 0
April 29, 2020: "The U.S. Food and Drug Administration granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration...

Coronavirus (COVID-19) Update: Daily Roundup April 28, 2020

admin - 0
April 28, 2020: "The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19...

ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer

admin - 0
April 28, 2020: "ERYTECH Pharma announced that the U.S. FDA has granted eryaspase Fast Track Designation for the development of a second-line treatment of...

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Use at an Additional Recommended Dose of 400 mg Every Six Weeks for All Approved Adult Indications

admin - 0
April 28, 2020: "Merck Known as MSD outside the United States and Canada announced that the U.S.FDA has approved an additional recommended dosage...

Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox

admin - 0
April 28, 2020: "Chimerix, a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases announced that the...

Shionogi Accelerates Development of Potential COVID-19 Treatments and Vaccine

admin - 0
April 28, 2020: "In response to the novel coronavirus (SARS-CoV-2), Shionogi & Co., Ltd. has joined the ranks of pharmaceutical companies across the globe...

ViiV Healthcare announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment and...

admin - 0
April 27, 2020: "ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders announced the creation...
1...444546...65Page 45 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved